
doi: 10.1002/path.4441
pmid: 25212381
AbstractKaposi sarcoma (KS) is an unusual vascular tumour caused by an oncogenic‐herpesvirus, Kaposi sarcoma‐associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV 8). KS lesions are characterized by an abundant inflammatory infiltrate, the presence of KSHV‐infected endothelial cells that show signs of aberrant differentiation, as well as faulty angiogenesis/ vascularization. Here we discuss the molecular mechanisms that lead to the development of these histological features of KS, with an emphasis on the viral proteins that are responsible for their development. Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Skin Neoplasms, Neovascularization, Pathologic, Virulence, Endothelial Cells, Cell Differentiation, Herpesviridae Infections, Cell Transformation, Viral, Risk Factors, Herpesvirus 8, Human, Host-Pathogen Interactions, Animals, Humans, Sarcoma, Kaposi, Cell Proliferation
Skin Neoplasms, Neovascularization, Pathologic, Virulence, Endothelial Cells, Cell Differentiation, Herpesviridae Infections, Cell Transformation, Viral, Risk Factors, Herpesvirus 8, Human, Host-Pathogen Interactions, Animals, Humans, Sarcoma, Kaposi, Cell Proliferation
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 101 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
